vTv Therapeutics Inc.
4170 Mendenhall Oaks Pkwy
High Point, NC 27265
March 15, 2018
VIA EDGAR
Division of Corporation Finance
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
vTv Therapeutics Inc.
Registration Statement on
Form S‑3 (File No. 333-223269)
Registration Statement on
Form S‑3 (File No. 333-223269)
Dear Mr. Edwards:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, we hereby request that the effective date of the above-captioned Registration Statement on Form S-3 (the “S-3”) of vTv Therapeutics Inc. (the “Company”) be accelerated to March 19, 2018 at 4:00 p.m. Eastern Time or as soon thereafter as may be practicable.
We understand that the Staff will consider this request as confirmation by the Company of its awareness of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. If you have any questions regarding the foregoing, please contact Lawrence G. Wee of Paul, Weiss, Rifkind, Wharton & Garrison LLP at (212) 373-3052.
*****
|
Very truly yours,
|
|||
|
VTV THERAPEUTICS INC.
|
|||
|
|
By:
|
/s/ Rudy Howard | |
| Name: Rudy Howard | |||
| Title: Chief Financial Officer | |||